New Cousteau-Linked...
Health Care: Health Services
AngioDynamics Inc. (ANGO: NASDAQ)
$11.90 -0.14 | -1.16%
06/01/12 - 04:00 PM ET
Company Cash Flow
| May 2011 | May 2010 | May 2009 | May 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 8.12M | 12.31M | 9.93M | 10.89M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 41.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 2.77M | -2.61M | 351.00K | -6.13M |
| (Increase) Decrease in Inventories | 1.50M | 8.30M | -10.53M | 4.17M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -2.43M | 1.52M | 5.57M | 2.34M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | -933.00K | 33.00K |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | -7.00M |
| Other Non-Cash Items | 10.08M | 3.34M | 256.00K | 9.51M |
| Net Cash From Continuing Operations | 33.87M | 39.96M | 19.94M | 25.91M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 33.87M | 39.96M | 19.94M | 25.91M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 124.08M | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -2.96M | -10.45M | -21.44M | -6.71M |
| Acquisitions | -1.09M | 0.00 | 0.00 | -18.69M |
| Purchases of Short-Term Investments | -168.48M | -42.44M | -33.98M | -2.51M |
| Other Cash from Investing Activities | -182.00K | 0.00 | 0.00 | 1.72M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -48.62M | -11.78M | -15.70M | -26.19M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 2.18M | 2.88M | 1.77M | 4.24M |
| Repayment of Long-Term Debt | -260.00K | -265.00K | -10.04M | -315.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 108.00K | 0.00 | 91.00K |
| Net Cash From Financing Activities | 1.92M | 2.72M | -8.27M | 4.01M |
| Effect of Exchange Rate Changes | 49.00K | -46.00K | -108.00K | 0.00 |
| Net Change in Cash & Cash Equivalents | -12.78M | 30.85M | -4.13M | 3.73M |
Portfolios with ANGO
- Portfolio NameUser Type
- UserMedical devices M&A
- ContributorEarnings Short Squeeze Play...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserLast Day of the JPMorgan He...
- UserDrewski2 Portfolio 1
- Userwafessler Portfolio 1
- UserRPavlovic Portfolio 1
- UserGluck Portfolio 1
- Userchappervester Portfolio 1
Latest ANGO Headlines from TheStreet
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- AngioDynamics' CEO Discusses Q3 2012 Results - Earnings Call Transcript 04.04.12 | 08:04 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 03.09.12 | 04:03 am
- AngioDynamics Inc. Presents At The 30th Annual JPMorgan Chase Healthcare Conference, Jan-12-2012 10:30 AM 01.12.12 | 08:01 pm
- AngioDynamics Inc. Stock Upgraded (ANGO) 01.09.12 | 05:01 am
- AngioDynamics' CEO Discusses Q2 2012 Results - Earnings Call Transcript 01.05.12 | 10:01 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 11.29.11 | 06:11 am
- AngioDynamics Inc. Stock Upgraded (ANGO) 10.26.11 | 07:10 am
- AngioDynamics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 10.06.11 | 09:10 pm
- 5 Earnings Stocks to Squeeze the Bears 10.04.11 | 01:10 pm
Press Releases for ANGO
- NanoKnife® System Clinical Experience Featured At Society Of Surgical Oncology Conference - Business Wire 04.02.12 | 06:04 am
- Five Oral Presentations On Clinical Experience With NanoKnife® System Featured At Society Of Interventional Radiology Conference - Business Wire 03.29.12 | 06:03 am
- AngioDynamics Establishes Strategic Relationship With Microsulis Medical Ltd. - Business Wire 03.26.12 | 06:03 am
- Scott Solano To Depart AngioDynamics - Business Wire 09.22.11 | 04:09 pm
- AngioDynamics Names Joseph M. DeVivo President And CEO - Business Wire 08.16.11 | 07:08 am
- AngioDynamics Reports Fiscal 2011 Fourth Quarter And Full Year Financial Results - Business Wire 07.14.11 | 04:07 pm
- AngioDynamics To Report Fiscal 2011 Fourth Quarter And Full Year Financial Results And Hold Conference Call On July 14, 2011 - Business Wire 07.05.11 | 06:07 am
- AngioDynamics Reports Preliminary Fiscal 2011 Fourth Quarter Financial Results And Corporate Developments - Business Wire 06.13.11 | 04:06 pm
- AngioDynamics Launches VenaCure® 1470nm Laser For Treatment Of Varicose Veins - Business Wire 05.31.11 | 06:05 am
- AngioDynamics Expands VenaCure EVLT® System For Varicose Veins With Longer 90 Cm Kit - Business Wire 05.26.11 | 06:05 am
Partner Headlines for ANGO
- The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard - Press Releases - Zacks 05.24.12 | 09:05 am
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- 6 Insider Stock Picks Rated Buy By Canaccord Genuity - Seeking Alpha 02.10.12 | 05:02 pm
- AngioDynamics Cuts View on Recall - Analyst Blog - Zacks 01.27.12 | 07:01 pm
- AngioDynamics Beats, Tweaks View - Analyst Blog - Zacks 01.06.12 | 09:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BSD Promotes Hyperthermia Tech - Analyst Blog - Zacks 10.31.11 | 07:10 pm
- Bard's 3Q Mixed, Buying Medivance - Analyst Blog - Zacks 10.26.11 | 09:10 am
- AngioDynamics Trades Lower on Q1 Earnings Results - Benzinga 10.06.11 | 04:10 pm
- Company News for June 16, 2011 - Corporate Summary - Zacks 06.16.11 | 10:06 am
